Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com, and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. You can reach Anthony at Info@TheMarijuanaHerald.com.
Anthony Martinelli
Author's posts
Safe Harbor Launches First Full-Scale Financial Solutions Platform for Marijuana Industry
Safe Harbor has launched what it describes as the industry’s first end-to-end financial solutions platform. The platform arrives ten years after Safe Harbor rolled out the country’s first compliant marijuana banking program. Since then, operators have continued to face the same core challenges: limited access to capital, complex regulations, high taxes and a lack of …
Virginia Commission Set to Unveil Final Recreational Marijuana Sales Proposal on December 2
Virginia lawmakers are preparing to unveil a long-awaited framework for launching adult-use marijuana sales, with the Joint Commission on the Future of Cannabis Sales set to present its final proposal at its December 2 meeting. The commission’s plan represents the most significant movement toward a regulated market since Virginia legalized possession and home cultivation in …
Breaking New Ground: IGC-AD1 Targets Agitation in Alzheimer’s With a Cannabis-Based Investigational Therapy
IGC Pharma is advancing a new approach to one of the most difficult and exhausting symptoms of Alzheimer’s disease: agitation. The company’s investigational therapy, IGC-AD1, is now in a Phase 2 clinical study known as the CALMA trial, and early data show meaningful reductions in agitation along with signals that may point to potential cognitive …
Study: Balanced THC/CBD Formula Protects Developing Brain Cells From Hypoxia-Related Damage
A study published today by the peer-reviewed journal Neurotoxicity Research reports that a balanced 1:1 combination of THC and CBD may help shield developing neural cells from the damaging effects of hypoxia. The study comes from scientists at Münster University and Tabriz University of Medical Science, who examined how Satinex, a clinically used 1:1 THC/CBD …
Study: CBD and CBDV Combination Reduces IBD-Related Gut Inflammation by Targeting Key Immune Receptor
A new study published in Biomedicine & Pharmacotherapy reports that a blend of cannabidiol (CBD) and cannabidivarin (CBDV) sharply reduces expression of a key immune receptor linked to inflammatory bowel disease. The research, conducted by scientists from the Technion-Israel Institute of Technology, offers evidence for a CB2-dependent cannabinoid interaction that may help explain the entourage …
Cannabis Use Linked to Reduce Risk of Oral Cancer, New Meta-Analysis Finds
A meta-analysis published this week by the Journal of Ethnological Substance Abuse reports that cannabis use is linked to a reduced risk of oral cancer. After reviewing thousands of participants across multiple case-control studies, the analysis found that marijuana use was associated with a reduced likelihood of developing oral cancer. It was conducted by researchers …
Study: CBD Combined With Natural Antioxidants Reduces Aggression and Depression-Like Symptoms in PTSD
A new study published in Frontiers in Pharmacology reports that cannabidiol, when paired with common natural antioxidants, may significantly reduce aggression and depression-like behavior in a validated model of post-traumatic stress disorder. The research was conducted by scientists from Link Campus University, Biomedical Campus University of Rome, the University of Galway, and the University of …
Study: Autistic Adults Report 73% Short-Term Symptom Relief After Using Inhaled Cannabis
A new study published in Scientific Reports finds that autistic adults who use inhaled cannabis report large short-term reductions in core and co-occurring symptoms. The research was conducted by scientists from Washington State University and the University of New Orleans using anonymized data from the Strainprint journaling app.
Study: CBD Reduces Tumor Growth and Lowers Immune Evasion Marker HLA-G
A study published yesterday in the peer-reviewed journal Scientific Reports finds that cannabidiol may suppress a key immune-evasion molecule used by certain tumors while simultaneously reducing their growth and mobility. The findings come from experiments using JEG-3 choriocarcinoma cells, a model commonly used to study cancer behavior and immune-related pathways.
Massachusetts Marijuana Sales Reach $154 Million in October, $1.55 Billion Year-to-Date
Massachusetts adult-use marijuana sales climbed to $141.6 million in October (compared to $136 million in September), continuing a strong year for the state’s recreational market. Medical marijuana sales added another $12.7 million, bringing the combined monthly total to more than $154 million, according to data released today by the Cannabis Control Commission. The numbers reflect …
Sponsored
